Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
JTT-130 in obese type 2 diabetes
NCT00929539Phase 2Completed
- Sponsor
- Akros Pharma Inc.
- Start
- Jun 2009
- Primary completion
- May 2010
- Modality
- Small Molecules
- Countries
- 5
01
Overview
A Phase 2 trial of granotapide in type 2 diabetes mellitus (T2DM), obesity, sponsored by Akros Pharma Inc.. Started Jun 2009; status: completed.
02
Drugs
granotapide
03
Conditions
type 2 diabetes mellitus (T2DM)obesity
Beyond the preview
Go deeper on NCT00929539.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00929539.